Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults-Reference-Cited by-同舟云学术

Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Published:2016-05-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Epstein Tamir¹,Patsopoulos Nikolaos A²,Weiser Mark³⁴

Affiliation:

1. The Chaim Sheba Medical Center; Department of Psychiatry; Affiliated to the Tel-Aviv University Sackler School of Medicine Tel Hashomer Israel 52621

2. Brigham and Women's Hospital, Harvard Institutes of Medicine; Department of Neurology; BWH/Neurology - Rm 150 77 Avenue Louis Pasteur Boston MA USA 02115

3. The Chaim Sheba Medical Center, Affiliated to the Tel-Aviv University; Department of Psychiatry; Tel Hashomer Israel 52621

4. Sackler School of Medicine; Department of Psychiatry; Tel Aviv Israel

Publisher

Wiley

Subject

Pharmacology (medical)

Reference89 articles.

1. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder;Bouffard;Canadian Journal of Psychiatry,2003

2. Attention deficit disorders in adults;Gualtieri;Clinical Neuropharmacology,1985

3. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD;Boonstra;Journal of Clinical and Experimental Neuropsychology,2005

4. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial;Kooij;Psychological Medicine,2004

5. Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults;Kuperman;Annals of Clinical Psychiatry,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Cochrane Database of Systematic Reviews;2023-03-27

2. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults;Cochrane Database of Systematic Reviews;2022-02-24

3. Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile;BMJ Evidence-Based Medicine;2020-04-24

4. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults;Cochrane Database of Systematic Reviews;2017-11-15

5. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults;Cochrane Database of Systematic Reviews;2016-05-26